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Free-of-chargea b s t r a c t
Objective: To identify factors associated with choosing long-acting reversible contraception (LARC) (in-
trauterine device or contraceptive implant), when provided free-of-charge.
Study design: This register-based cohort study comprises all women living in the city of Vantaa in the
Helsinki metropolitan area during 2013–2014, with information on LARC initiations retrieved from elec-
tronic health records. Since January 2013, women in Vantaa can receive their first LARC method free-of-
charge at public contraceptive clinics. We performed multivariable regression to assess seven predictors
based on literature and four predictors based on gynecological history for association with choosing LARC
in this population.
Results: In 2013–2014, 9669 women entitled to a free-of-charge method visited a public clinic and 2035
(21.0%) women initiated LARC. Factors most associated with LARC initiation included history of delivery
(odds ratio [OR] 5.4, 95% confidence intervals [CI] 4.7–6.2) and induced abortion (OR 1.4, 95%CI 1.2–1.6),
and no previous visit at the clinic (OR 1.3, 95%CI 1.2–1.5). Previous delivery was associated with LARC
initiation in all age-groups (OR, 95%CI by age-group; 15–19 years: 10.8, 5.1–23.4; 20–24 years: 6.4,
4.9–8.3; 25–29 years: 6.7, 5.2–8.6; 30–44 years: 3.6, 2.9–4.6).
Conclusion: History of delivery and induced abortion were strongly associated with choosing a LARC
method, even though all women in the population were entitled to their first free-of-charge LARC
method. The association was particularly strong among women less than 25 years of age.
Implications statement: Untargeted provision of free-of-charge LARC in public contraceptive services
reached women with previous delivery or abortion well during the programs first years. However, as
LARCs are recommended to all women, future research should focus on how uptake evolves and how
to reach all women in need of long-term, effective contraception.
 2020 Elsevier Inc. All rights reserved.1. Introduction
Long-acting reversible contraception (LARC) – i.e. intrauterine
devices and contraceptive implants – are the most effective rever-
sible contraceptives available, but still used far less than short-
acting methods [1].
Previous studies have identified several factors associated with
initiating or planning to initiate LARC. These factors include history
of delivery, childbearing at young age, age under 35, higher educa-
tional level, history of unintended pregnancy or induced abortion
(hereafter abortion), being married and poverty or low socioeco-
nomic status, although results vary between studies [1–5]. Inter-
estingly, many of these characteristics are also found among
women with unintended pregnancies or abortions [6,7]. On the
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risk of unintended pregnancy [6], but higher LARC uptake [2].
Although LARC use has been advocated as a tool to eliminate
health disparities regarding unintended pregnancy [8], the poten-
tial risk of targeting perceived high-risk women has also been dis-
cussed [9,10].
Price is often a barrier for choosing LARC [11], as these methods
frequently have high up-front costs. When costs have been
reduced by free-of-charge programs in several US settings, LARC
initiation has increased [12–14]. In the city of Vantaa in the Hel-
sinki metropolitan area, Finland, all women have been provided
their first LARC method free-of-charge at public contraceptive clin-
ics since January 2013. We have previously shown that LARC
uptake increased rapidly after introduction of this program and
the abortion rate declined, especially among adolescents [15].
The abortion rate was 80% lower among women choosing a free-
of-charge LARC method compared to women not initiating a LARC
method [16].
To better understand LARC use in populations for whom cost is
not a barrier, we reviewed medical records of women seen at pub-
lic clinics in Vantaa during 2013 and 2014 to identify those who
chose LARC. Our primary aim was to investigate predictors of
choosing LARC in this public program. Our secondary aim was to
investigate whether there was evidence of interactions between
age and other predictors and if so, to stratify the analysis by age
group.2. Material and methods
2.1. Setting
In Finland, public health care is markedly subsidized with
patient costs for uncomplicated childbirth of approximately €100
(US$110), and medical abortion of €33 (US$37, European central
bank exchange rate 2019, www.ecb.europa.eu). Pregnancy and
postpartum care encompasses 11 visits at maternity clinics, all
free-of-charge. Attendance at maternity clinics reaches 99% [17],
as substantial maternity benefits are tied to these visits. After abor-
tion, a follow-up visit is recommended by the Finnish national
abortion guideline [18], but this visit is not linked to any benefits.
In 2013–2014, 70% of abortion clients attended abortion follow-up
visits in Vantaa, according to statistics from electronic health
records. Contraceptive services are guaranteed by law and avail-
able free-of-charge for all and include contraceptive counseling,
LARC insertion and removal, laboratory tests when needed, and
abortion referrals and follow-up visits [19]. Contraceptive methods
are not universally reimbursed but are moderately priced (e.g. €5–
13 (US$6–14)/month for oral contraceptives, €155 (US$172) for
levonorgestrel intrauterine systems). Additionally, some munici-
palities provide contraceptives free-of-charge at public clinics.
Women in Vantaa frequently use public contraceptive services,
with approximately one fourth of 15- to 24-year-old women visit-
ing a clinic in 2014 [15].
LARC initiation is registered in Vantaa’s electronic health
records. Registration entitles general practitioners to a minor pay
supplement (€7, US$8).2.2. Study population
Our study population consists of all 15- to 44-year-old women
entitled to a free-of-charge LARC method in Vantaa during the
years 2013 and 2014. The two study groups comprise clients at
public contraceptive clinics, either initiating or not initiating a
free-of-charge method during this time. We have previously
described formation of the study groups, their baseline character-istics, and study entering [16]. Only the first LARC method is pro-
vided free-of-charge; previous insertions or removals renders
women not eligible. We excluded women with either a LARC inser-
tion or removal during or after year 2000, women with baseline
pregnancies ending in 2015, and women using permanent contra-
ception (Fig. 1).
LARC methods provided included Copper (Cu) T380A intrauter-
ine device (IUD), levonorgestrel (LNG) 52 mg intrauterine system
(IUS), LNG 13.5 mg IUS, (since 2014), etonogestrel (ENG) implant
and LNG two-rod implant.2.3. Data sources
We identified all women who received free-of-charge LARC at a
public clinic in 2013–2014. First, LARC insertion visits were
retrieved by a computerized search of the electronic health
records. Second, three members of the research team (two physi-
cians [F.G. and T.S.] and a trained study nurse) reviewed the corre-
sponding health records to confirm the clinic provided the LARC
method free-of-charge. More than one researcher checked fifty vis-
its to confirm the other’s findings with no discrepancies identified.
We also computed a binary variable of having no previous visit(s)
during two years before start of study from the health records, to
facilitate adjusting for previous contraceptive counseling.
We used validated Finnish national registers to obtain back-
ground information on the study participants [20–23]; all Finnish
residents can be identified in these registers by a unique personal
identification code. We used the Medical Birth Register (available
since 1987), the Register of Induced Abortions (1983), the Steriliza-
tion Register (1987), and the Hospital Discharge Register (1969)
and Primary Care Register (2011) for information on diagnosis of
heavy, irregular or frequent menstrual bleeding (hereafter abnor-
mal uterine bleeding, ICD-10 code N92), dysmenorrhea and other
symptoms associated with the menstrual cycle (hereafter dysmen-
orrhea; ICD-10 code N94) and endometriosis (ICD-10 code N80).
Further, we obtained information on Chlamydia Trachomatis, Neis-
seria Gonorrhea, and Treponema Pallidum infections from the Regis-
ter of Infectious Diseases (1995).
We obtained information on the number of women in Vantaa as
well as marital status and native language from the population reg-
ister of Vantaa, and socio-economic status and educational level
from Statistics Finland. As native language is a proxy for race or
being an immigrant in Finland, we coded native language as a bin-
ary variable of speaking one of the two national languages in Fin-
land (Finnish and Swedish). We coded education as a binary
variable of having more or no more than elementary education.
Socioeconomic status was defined as a five-category variable, with
the group ´ otheŕ comprising farmers, students, unemployed,
retired, and housewives. The fifth group ‘unknown’ included
women with no data on socioeconomic status in national registers.2.4. Statistical methods
We combined the two LNG IUSs and the two contraceptive
implants for all analyses. To explore whether effect of age was lin-
ear, we fitted a restricted cubic spline of age and observed a non-
linear association (P < 0.001). Based on the spline function we used
a four-category age variable in the regression models to assess age-
group-specific ORs; 15- to 19-year-olds, 20- to 24-year-olds and
25- to 29-year-olds and 30- to 44-year-olds, with the oldest age
group used as reference group.
We calculated frequencies for all variables in the two study
groups, and by LARC method choice; LNG IUS, Cu IUD, or contra-
ceptive implant, repeating the same calculations in the four age
groups. We compared the distributions of categorical data by
Fig. 1. Flow-chart of the formation of the study groups from the complete 15- to 44-year-old female population in Vantaa during 2013–2014.
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son’s Chi-square test or Fisher exact test, as appropriate.
To identify factors associated with choosing free-of-charge
LARC, we fitted logistic regression models to obtain odds ratios
(OR) with 95% confidence intervals (CI). First, we calculated crude
ORs for seven factors previously established in the literature to
associate with choosing a LARC method: age, history of delivery,
history of abortion, marital status, educational level, socioeco-
nomic status and speaking a national language as native language
[1–5]. We then selected variables to include in the multivariate
model by eliminating candidate predictors using backward elimi-
nation with Akaike’s information criterion (AIC) as stopping rule,
i.e. decreasing AIC for an improved model, reinserting excluded
variables one by one and all together to further check whether
including these variables improved the model [24]. This model
selection yielded a model with categorical age, history of delivery,
history of abortion and marital status as predictive variables. We
opted to omit variables on educational level, socioeconomic status
and native language because they did not improve the model. To
examine whether variables on gynecological morbidity would fur-
ther improve the model, we added prior diagnoses of abnormal
uterine bleeding, dysmenorrhea, sexually transmitted infections,
and no previous visits at clinics. We only found 35 women with
endometriosis so we did not include this variable in the model.Because recent diagnoses are likely to be stronger predictors and
hence of greater clinical relevance, we included diagnoses and
infections from two years preceding the start of follow-up. We
repeated the model selection procedure with the variables on
gynecological morbidity to obtain the final regression model and
found that diagnosed dysmenorrhea and being a first-time client
improved the model. History of sexually transmitted infection
and abnormal uterine bleeding did not improve the model and
were not included.
Because the age span in the study population is wide and need
and use of contraceptives vary with age, we further estimated an
interaction model with the interaction of categorical age and the
other predictive variables. We found evidence of significant inter-
action with categorical age and history of delivery, abortion, dys-
menorrhea and being a first-time client, and continued to run the
main model stratified by the four age categories.
We considered p < 0.05 as statistically significant and con-
ducted all analyses using R statistical software (version 3.5.3).2.5. Ethics approval
The ethics committee of the Hospital District of Helsinki and
Uusimaa assessed and approved the study together with the
F. Gyllenberg et al. / Contraception 101 (2020) 370–375 373register keeping organizations of the registers used (City of Vantaa,
National Institute for Health and Welfare and Statistics Finland).3. Results
Of all 48,846 15- to 44-year-old women eligible to a free-of-
charge LARC method, 9669 visited a public clinic in 2013–2014
and 2035 (21.0%) initiated a free-of-charge LARCmethod. The char-
acteristics of women who did and did not choose LARC as well as
women’s characteristics across the three LARC methods differed
significantly and are presented in Table 1. Particularly, women
choosing LARC were older, and more frequently had history of
delivery and abortion. The subject characteristics according to
the four age groups are shown in Supplementary Table 1.
In the final multivariate regression model, five factors remained
significantly associated with choosing free-of-charge LARC: age 20-
to 24-years, history of abortion, history of delivery, being married
and no previous visit at a clinic. Previous delivery had the highest
OR of 5.39 (95% CI 4.69–6.19). Odds Ratios for initiating a LARC
method from crude and adjusted regression models are presented
in Table 2, and the results from the final multivariate model are
summarized Fig. 2. The ORs for choosing a LARC method in the
three younger age categories were less than 1 in the crude model,
but greater than 1 after adjustment, compared to the reference
group of 30- to 44-year-olds. We further examined this change
by looking at two-variable-models with categorical age and the
other variables and found the shift to occur after adjustment for
delivery.
We present the interactions between categorical age and the
other predictors, when tested one at a time with the logistic regres-
sion model for LARC initiation, in Supplementary Table 3. We
found significant interactions between categorical age and prior
delivery (P = 0.006 for 15- to 19-year-olds, P = 0.001 for 20- to
24-year-olds, and P < 0.001 for 25- to 29-year-olds), prior abortion
(P < 0.001 for 15- to 19-year-olds and P = 0.005 for 20- to 24-year-Table 1







15–19 1864 (24.4) 237 (11.6)
20–24 2361 (30.9) 453 (22.3)
25–29 1518 (19.9) 475 (23.3)
30–44 1891 (24.8) 870 (42.8)
History of delivery 1818 (23.8) 1,308 (64.3)
History of abortion 1099 (14.4) 483 (23.7)
Married 1556 (20.4) 804 (39.5)
Only elementary education 2519 (33.0) 598 (29.4)
Socioeconomic statusa
Upper-level employees 522 (6.8) 225 (11.1)
Lower-level employees 2889 (37.8) 799 (39.3)
Manual workers 1481 (19.4) 376 (18.5)
Other 2341 (30.7) 486 (23.9)
Unknown 401 (5.3) 149 (7.3)
Native language Finnish or Swedish 6637 (86.9) 1676 (82.4)
No previous visit at clinicb 4336 (56.8) 1401 (68.8)
History of abnormal uterine bleedingb 179 (2.3) 54 (2.7)
History of dysmenorrheab 141 (1.8) 42 (2.1)
History of STIb 331 (4.3) 59 (2.9)
Note: Data are presented as n (% of group total). p-value obtained by X2 and Fisher exac
Abbreviations: LARC: Long-acting reversible contraception, LNG IUS: levonorgestrel int
intrauterine device, Implant: etonogestrel implant and levonorgestrel 2-rod implant, S
Treponema Pallidum).
aSocioeconomic status classified according to Statistics Finland standards: Upper-level
Lower-level employees with administrative and clerical occupations; Manual workers a
bWithin two years before start of study.olds), no previous visit at clinics (P < 0.001 for 15- to 19-year-olds
and P = 0.03 for 20- to 24-year-olds) and history of dysmenorrhea
diagnosis (P = 0.01 for 15- to 19-year-olds and P < 0.001 for 20- to
24-year-olds). Hence, we repeated the regression model in the four
age groups (Fig. 3 and Supplementary Table 2). History of delivery
remained statistically significant, with the highest OR of all vari-
ables in all age groups (ORs between 3.63 and 10.82). History of
abortion was significantly associated with choosing LARC among
15- to 19- and 20- to 24-year-olds (ORs 3.16 [95% CI 1.91–5.11]
and 1.82 [95% CI 1.39–2.37], respectively). Among 20- to 24-
year-olds, prior diagnosis of dysmenorrhea was associated with
choosing LARC (OR 3.78 [95% CI 2.06–6.73]). Being a new customer
at the contraceptive clinic reduced the odds of choosing free-of-
charge LARC in the youngest age group (OR 0.73 [95%CI 0.55–
0.97]) but increased the odds in the three older groups.4. Discussion
We found that parous women more likely chose free-of-charge
LARC as compared to nulliparous women, with the highest odds in
the youngest (15–19 years) age group. Among women less than
25 years of age, women choosing LARCs also more often had a prior
abortion. We surmise that these women are more motivated to ini-
tiate a long-acting effective contraceptive compared to older
women with a history of delivery or abortion.
Although the public program in Vantaa was not designed to tar-
get risk groups but provided all women their first LARC method
free-of-charge, women who chose LARCs had characteristics simi-
lar to women with an unintended pregnancy choosing abortion
[6,7,25]. The same characteristics have been identified in free-of-
charge programs in the US, with history of unintended pregnancy
and childbirth increasing the odds of choosing LARC [26,27]. This
phenomenon might be explained in part by the service providers
to characterize women as ‘‘high-risk” for unintended pregnancy










49 (4.1) 5 (2.7) 183 (28.3)
209 (17.4) 43 (23.1) 201 (31.1)
296 (24.6) 64 (34.4) 147 (22.8)
649 (53.9) 74 (39.8) 147 (22.8)
<0.001 954 (79.3) 127 (68.3) 227 (35.1) <0.001
<0.001 312 (25.9) 50 (26.9) 121 (18.7) 0.001
<0.001 564 (46.9) 84 (45.2) 156 (24.1) <0.001
<0.001 269 (22.4) 48 (25.8) 281 (43.4) <0.001
<0.001 <0.001
166 (13.8) 24 (12.9) 35 (5.4)
516 (42.9) 66 (35.5) 217 (33.6)
214 (17.8) 38 (20.4) 124 (19.2)
215 (17.9) 47 (25.2) 224 (34.7)
92 (7.6) 11 (5.9) 46 (7.1)
<0.001 1012 (84.1) 122 (65.6) 542 (83.9) <0.001
<0.001 882 (73.3) 131 (70.4) 388 (60.1) <0.001
0.47 38 (3.2) 3 (1.6) 13 (2.0) 0.25
0.58 23 (1.9) 1 (0.5) 18 (2.8) 0.15
0.006 25 (2.1) 2 (1.1) 32 (5.0) <0.001
t test for small expected values.
rauterine system (includes 52 mg and 13.5 mg products, Cu IUD: T380A Copper
TI: Sexually transmitted infection (Chlamydia Trachomatis, Neisseria Gonorrhea or
employees with administrative, managerial, professional and related occupations;
nd others including farmers, students, unemployed, retired, and housewives.
Table 2
Odds ratios for predictors of initiating LARC from crude and adjusted logistic regression models in the 15- to 44-year-old female population in Vantaa attending a public clinic in
2013–2014 and eligible for free-of-charge LARC.
Crude Model Adjusted Model
OR (95% CI) p-value OR (95% CI) p-value
Age 15–19 0.28 (0.24–0.32) <0.001 1.15 (0.94–1.41) 0.16
Age 20–24 0.42 (0.37–0.47) <0.001 1.25 1.07–1.47) 0.01
Age 25–29 0.68 (0.60–0.77) <0.001 1.08 (0.94–1.25) 0.29
Age 30–44 ref ref
History of delivery 5.76 (5.18–6.39) <0.001 5.39 (4.69–6.19) <0.001
History of abortion 1.85 (1.64–2.09) <0.001 1.39 (1.21–1.58) <0.001
Married 2.55 (2.30–2.83) <0.001 1.23 (1.08–1.4) 0.001
Only elementary education 0.81 (0.73–0.90) <0.001 –
Socioeconomic statusa
Upper-level employees ref –
Lower-level employees 0.64 (0.54–0.77) <0.001 –
Manual workers 0.59 (0.49–0.71) <0.001 –
Other 0.48 (0.4–0.58) <0.001 –
Unknown 0.86 (0.67–1.1) 0.23 –
Native language Finnish or Swedish 1.43 (1.25–1.63) <0.001 –
No previous visit at clinicb 1.68 (1.52–1.87) <0.001 1.31 (1.17–1.46) <0.001
History of abnormal uterine bleedingb 1.14 (0.83–1.53) 0.42 –
History of dysmenorrheab 1.12 (0.78–1.57) 0.52 1.4 (0.95–2.02) 0.08
History of STIb 0.67 (0.51–0.88) 0.01 –
Abbreviations: LARC: Long-acting reversible contraception, OR: Odds Ratio, CI: Confidence Interval, STI: Sexually transmitted infection (Chlamydia Trachomatis, Neisseria
Gonorrhea or Treponema Pallidum).
aSocioeconomic status classified according to Statistics Finland standards: Upper-level employees with administrative, managerial, professional and related occupations;
Lower-level employees with administrative and clerical occupations; Manual workers and others including farmers, students, unemployed, retired, and housewives.
bWithin two years before start of study.
Fig. 2. Forest plot of crude and adjusted odds ratios of the predictors of initiating a free-of-charge LARC method. Results based on logistic regression models among 15- to 44-
year-old women attending a public clinic and eligible for free-of-charge LARC. Abbreviations: OR: odds ratio, CI: confidence interval.
374 F. Gyllenberg et al. / Contraception 101 (2020) 370–375of pregnancy choose to rely on these reliable reversible contracep-
tive methods, it is equally important to provide women with no
such history counseling on LARC methods.
High acceptance of LARC among women with a history of deliv-
ery or abortion may also be explained in part by the Finnish health
care system. After both delivery and abortion, all women are
invited to a follow-up visit, which includes contraceptive counsel-
ing per Finnish national guidelines. Short-acting methods can be
prescribed at these visits, while LARC usually require another visit.
Even though same-day insertions have been shown to markedly
increase LARC uptake [30], this program reached women with prior
induced abortion and delivery particularly well. Still, LARC uptake
might have been even higher if same-day insertions at follow-up
visits would have been available.A major strength of this study is its real-world setting, which
facilitates analyzing factors associated with choosing LARC when
price is eliminated as a barrier. Our study population consisted of
the complete eligible population and all women using public con-
traceptive services. Additionally, with use of the high-quality Fin-
nish national registers, we investigated whether previous
gynecological diagnoses and sexually transmitted infections were
associated with choosing a LARC method. A limitation is that the
findings may be unique to the City of Vantaa. The Finnish universal
health care system differs from systems in other countries, which
may affect the generalizability of the results. Further, the variable
use of diagnostic codes might underestimate the real number of
women with symptoms, as it is possible that mild symptoms are
not registered in patient records.
Fig. 3. Forest plot of adjusted odds ratios of the predictors of initiating a free-of-charge LARC method in the four age groups. Results based on logistic regression models
stratified by the four age groups (15- to 19-year-olds, 20- to 24-year-olds, 25- to 29-year-olds, 30- to 44-year-olds) of women attending a public clinic and eligible for free-of-
charge LARC. Abbreviations: OR: odds ratio, CI: confidence interval.
F. Gyllenberg et al. / Contraception 101 (2020) 370–375 375We conclude that a public program providing the population
with LARC free-of-charge reaches women at high-risk for unin-
tended pregnancy well. A challenge is to ensure that all women,
regardless of their characteristics, receive high-quality LARC coun-
seling and provision.
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